Clinical Trial Update: Oral Immunotherapy for Childhood Egg Allergy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating oral immunotherapy for childhood egg allergy has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Egg Allergy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hypersensitivity, Immediate Hypersensitivity | Phase 2 | Status: COMPLETED | Results posted: 2012-05-01